The 12 closest competitors and alternatives to Mana.bio among drug delivery companies — ranked by similarity to what Mana.bio actually does, not by market-cap band.
Subscribe to see Mana.bio’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Mana.bio is an AI-based drug delivery startup headquartered in Tel Aviv, Israel, focusing on gene therapy and lipid nanoparticle development for mRNA and oligonucleotide therapeutics. The company leverages artificial intelligence to create advanced platforms for next-generation vaccines and genetic medicines.
Mana.bio is a drug delivery company headquartered in Israel, founded in 2021. Its most recent funding round, Seed, raised $19.5M in October 2023. Xcout tracks 4 named people at Mana.bio, including Yogev Debbi (Co-Founder & CEO).
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Seed | $19.5M | 4 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Ranked by semantic similarity — how close each company is to Mana.bio by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Drug Discovery
Cassidy Bio is an AI-first biotechnology company founded in 2024 and based in Israel that is developing a programmable platform for gene editing. The company utilizes a genomic foundation model powered by artificial intelligence to design safer and more scalable gene editing therapies across various guides, editors, and delivery contexts.
Drug Discovery
Cellyrix Therapeutics is an Israeli biotechnology company that develops targeted cancer therapies by leveraging single-cell RNA sequencing and artificial intelligence. The firm operates as an oncology-focused drug discovery venture headquartered in Rehovot, Israel.
Drug Discovery
Generare is a biotechnology and artificial intelligence company headquartered in Paris, France, focused on commercial bioprospecting and decoding natural products.
Drug Discovery
Variational AI is a privately held biotechnology startup headquartered in Vancouver, British Columbia. Founded in 2019, the company focuses on drug discovery, utilizing artificial intelligence to identify novel drug-like small molecules. Recognized as an innovative AI enterprise in Canada, it develops advanced computational methods for pharmaceutical research.
Drug Discovery
Renasis Bio Ltd. is a stealth-mode private company headquartered in Rehovot, Israel, established in 2025. The firm is developing an AI-driven drug discovery platform focused on RNA-targeting small molecules to advance RNA druggability.
Drug Discovery
Promise Bio is a biotechnology research startup transforming immune-mediated disease treatment with advanced precision therapies. Headquartered in Tel Aviv, Israel, the company emerged from stealth following a seed investment.
Medtech
MgShell is a preclinical-stage biotechnology and drug delivery company focused on developing magnesium-based drug delivery systems. The company is headquartered in Milan, Italy.
Drug Discovery
Orbital Therapeutics is a biotechnology company developing RNA medicines, with a focus on engineered circular RNA and delivery technologies. Its programs are intended to address diseases that may benefit from durable, programmable protein expression, serving patients and healthcare providers through potential therapeutic products.
Drug Discovery
Founded in 2021 and headquartered in Shenzhen, China, MagicRNA Biotechnology Co., Ltd. is a clinical-stage biotechnology company focused on nucleic acid drug delivery and the research and development of next-generation mRNA and lipid nanoparticle technologies for the treatment of cancer and infectious diseases.
Deeptech
Atinary is an artificial intelligence company with operations in Silicon Valley and Switzerland, featuring headquarters in Menlo Park, California. The company provides a code-free AI platform that accelerates research, development, and discovery in molecular science and chemistry.
Agtech
Seed-X is a biotechnology research company based in Israel that utilizes artificial intelligence to revolutionize seed improvement and agricultural quality analysis.
Drug Discovery
Dillico is a French company founded in 2022 and headquartered in Meylan, France. The company specializes in processing and unleashing the full potential of mRNA manufacturing. It provides technological solutions and collects data to support advanced biopharmaceutical production.
Search any company we track to see its competitive set.
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Mana.bioand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →